Determinants of Serum Concentrations of Lipopolysaccharide-Binding Protein (LBP) in the Adult Population: The Role of Obesity

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Gonzalez Quintela, Arturo ^a   Alonso, Manuela ^a   Campos, Joaquin ^a   Vizcaino, Luis ^a   Loidi, Lourdes ^b   Gude, Francisco ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b Fundacion Publica Galega de Medicina Xenomica   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE BINDING PROTEIN; LIVER ENZYME; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL OBESITY; ADULT; AGED; AGING; ALCOHOL CONSUMPTION; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; ENZYME BLOOD LEVEL; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENETIC POLYMORPHISM; HUMAN; IMMUNOASSAY; INFLAMMATION; INNATE IMMUNITY; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; METABOLIC SYNDROME X; OBESITY; PROTEIN BLOOD LEVEL; RANDOM SAMPLE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

ACUTE-PHASE PROTEINS; ADOLESCENT; ADULT; AGE FACTORS; ANTIGENS, CD14; CARRIER PROTEINS; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; IMMUNITY, INNATE; INFLAMMATION; MALE; MEMBRANE GLYCOPROTEINS; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; TOLL-LIKE RECEPTOR 4;

EID: 84872785949     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054600     Document Type: Article

References (68)

1. Bosshart H, Heinzelmann M, (2007) Targeting bacterial endotoxin. Two sides of a coin. Ann NY Acad Sci 1096: 1-17.
2. Stoll LL, Denning GM, Weintraub NL, (2004) Potential role of endotoxin as a proinflammatory mediator of atherosclerosis. Arterioscler Thromb Vasc Biol 24: 2227-2236.
3. Bazil V, Strominger JL, (1991) Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. J Immunol 147: 1567-1574.
4. Bas S, Gauthier BR, Spenato U, Stingelin S, Gabay C, (2004) CD14 is an acute-phase protein. J Immunol 172: 4470-4479.
5. Tobias PS, Soldau K, Ulevitch RJ, (1986) Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum. J Exp Med 164: 777-793.
6. Tobias PS, Ulevitch RJ, (1993) Lipopolysaccharide binding protein and CD14 in LPS dependent macrophage activation. Immunobiology 187: 227-232.
7. Schumann RR, Leong SR, Flaggs GW, Gray PW, Wright SD, et al. (1990) Structure and function of lipopolysaccharide binding protein. Science 249: 1429-1431.
8. Schumann RR, (2011) Old and new findings on lipopolysaccharide-binding protein: a soluble pattern-recognition molecule. Biochem Soc Trans 39: 989-993.
9. Hudgins LC, Parker TS, Levine DM, Gordon BR, Saal SD, et al. (2003) A single intravenous dose of endotoxin rapidly alters serum lipoproteins and lipid transfer proteins in normal volunteers. J Lipid Res 44: 1489-98.
10. Triantafilou M, Triantafilou K, (2002) Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends Immunol 23: 301-304.
11. Moshage H, (1997) Cytokines and the hepatic acute phase response. J Pathol 181: 257-266.
12. Gutsmann T, Müller M, Carroll SF, MacKenzie RC, Wiese A, et al. (2001) Dual role of lipopolysaccharide (LPS)-binding protein in neutralization of LPS and enhancement of LPS-induced activation of mononuclear cells. Infect Immun 69: 6942-6950.
13. Schröder NW, Schumann RR, (2005) Non-LPS targets and actions of LPS binding protein (LBP). J Endotoxin Res 11: 237-242.
14. Opal SM, Scannon PJ, Vincent JL, White M, Carroll SF, et al. (1999) Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J Infect Dis 180: 1584-1589.
15. Schumann RR, Latz E, (2000) Lipopolysaccharide-binding protein. Chem Immunol 74: 42-60.
16. Cohen J, (2000) The detection and interpretation of endotoxaemia. Intensive Care Med 26Suppl 1: S51-S56.
17. Novitsky TJ, (1998) Limitations of the Limulus amebocyte lysate test in demonstrating circulating lipopolysaccharides. Ann N Y Acad Sci 851: 416-421.
18. Sun L, Yu Z, Ye X, Zou S, Li H, et al. (2010) A marker of endotoxemia is associated with obesity and related metabolic disorders in apparently healthy Chinese. Diabetes Care 33: 1925-1932.
19. Albillos A, de la Hera A, Gonzalez M, Moya JL, Calleja JL, et al. (2003) Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. Hepatology 37: 208-217.
20. Ruiz AG, Casafont F, Crespo J, Cayón A, Mayorga M, et al. (2007) Lipopolysaccharide-binding protein plasma levels and liver TNF-alpha gene expression in obese patients: evidence for the potential role of endotoxin in the pathogenesis of non-alcoholic steatohepatitis. Obes Surg 17: 1374-1380.
21. Lequier LL, Nikaidoh H, Leonard SR, Bokovoy JL, White ML, et al. (2000) Preoperative and postoperative endotoxemia in children with congenital heart disease. Chest 117: 1706-1712.
22. Lepper PM, Schumann C, Triantafilou K, Rasche FM, Schuster T, et al. (2007) Association of lipopolysaccharide-binding protein and coronary artery disease in men. J Am Coll Cardiol 50: 25-31.
23. Schafer C, Parlesak A, Schutt C, Bode CJ, Bode C, (2002) Concentrations of lipopolysaccharide binding protein, bactericidal/permeability-increasing protein, soluble CD14 and plasma lipids in relation to endotoxaemia in patients with alcoholic liver disease. Alcohol Alcohol 37: 81-86.
24. Parlesak A, Schäfer C, Schütz T, Bode JC, Bode C, (2000) Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease. J Hepatol 32: 742-747.
25. Campos J, Gonzalez-Quintela A, Quinteiro C, Gude F, Perez LF, et al. (2005) The-159C/T polymorphism in the promoter region of the CD14 gene is associated with advanced liver disease and higher serum levels of acute-phase proteins in heavy drinkers. Alcohol Clin Exp Res 29: 1206-1213.
26. González-Quintela A, Gude F, Boquete O, Rey J, Meijide LM, et al. (2003) Association of alcohol consumption with total serum immunoglobulin E levels and allergic sensitization in an adult population-based survey. Clin Exp Allergy 33: 199-205.
27. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults, (2001) Executive Summary of Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285: 2486-2497.
28. Gude F, Rey-Garcia J, Fernandez-Merino C, Meijide L, García-Ortiz L, et al. (2009) Serum levels of gamma-glutamyl transferase are associated with markers of nocturnal hypoxemia in a general adult population. Clin Chim Acta 407: 67-71.
29. Gonzalez-Quintela A, Campos J, Gude F, Perez LF, Tomé S, (2007) Serum concentrations of interleukin-8 in relation to different levels of alcohol consumption. Cytokine 38: 54-60.
30. Gonzalez-Quintela A, Campos J, Loidi L, Quinteiro C, Perez LF, et al. (2008) Serum TNF-alpha levels in relation to alcohol consumption and common TNF gene polymorphisms. Alcohol 42: 513-518.
31. Gonzalez-Quintela A, Alende R, Gude F, Campos J, Rey J, et al. (2008) Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities. Clin Exp Immunol 151: 42-50.
32. Zeng L, Gu W, Zhang AQ, Zhang M, Zhang LY, et al. (2012) A functional variant of lipopolysaccharide binding protein predisposes to sepsis and organ dysfunction in patients with major trauma. Ann Surg 255: 147-157.
33. LeVan TD, Bloom JW, Bailey TJ, Karp CL, Halonen M, et al. (2001) A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity. J Immunol 167: 5838-5844.
34. Campos J, Gude F, Quinteiro C, Vidal C, Gonzalez-Quintela A, (2006) Gene by environment interaction: the-159C/T polymorphism in the promoter region of the CD14 gene modifies the effect of alcohol consumption on serum IgE levels. Alcohol Clin Exp Res 30: 7-14.
35. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, et al. (2000) TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25: 187-191.
36. Gubern C, López-Bermejo A, Biarnés J, Vendrell J, Ricart W, et al. (2006) Natural antibiotics and insulin sensitivity: the role of bactericidal/permeability-increasing protein. Diabetes 55: 216-224.
37. Gonzalez-Quintela A, Vizcaino L, Gude F, Rey J, Meijide L, et al. (2010) Factors influencing serum total tryptase concentrations in a general adult population. Clin Chem Lab Med 48: 701-706.
38. Frazier TH, DiBaise JK, McClain CJ (2011) Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury. JPEN J Parenter Enteral Nutr 35(5 Suppl): 14S-20S.
39. Arrieta MC, Bistritz L, Meddings JB, (2006) Alterations in intestinal permeability. Gut 55: 1512-1520.
40. Farhadi A, Banan A, Fields J, Keshavarzian A, (2003) Intestinal barrier: an interface between health and disease. J Gastroenterol Hepatol 18: 479-497.
41. Ma TY, Hollander D, Dadufalza V, Krugliak P, (1992) Effect of aging and caloric restriction on intestinal permeability. Exp Gerontol 27: 321-333.
42. Saweirs WM, Andrews DJ, Low-Beer TS, (1985) The double sugar test of intestinal permeability in the elderly. Age Ageing 14: 312-315.
43. Creely SJ, McTernan PG, Kusminski CM, Fisher M, Da Silva NF, et al. (2007) Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab 292: E740-E747.
44. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, et al. (2008) Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57: 1470-1481.
45. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, et al. (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56: 1761-1772.
46. Brun P, Castagliuolo I, Di Leo V, Buda A, Pinzani M, et al. (2007) Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 292: G518-G525.
47. Hotamisligil GS, (2006) Inflammation and metabolic disorders. Nature 444: 860-867.
48. Amar J, Burcelin R, Ruidavets JB, Cani PD, Fauvel J, et al. (2008) Energy intake is associated with endotoxemia in apparently healthy men. Am J Clin Nutr 87: 1219-1223.
49. Ghanim H, Abuaysheh S, Sia CL, Korzeniewski K, Chaudhuri A, et al. (2009) Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance. Diabetes Care 32: 2281-2287.
50. Wigg AJ, Roberts-Thomson IC, Dymock RB, McCarthy PJ, Grose RH, et al. (2001) The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis. Gut 48: 206-211.
51. Targher G, (2010) Elevated serum gamma-glutamyltransferase activity is associated with increased risk of mortality, incident type 2 diabetes, cardiovascular events, chronic kidney disease and cancer- a narrative review. Clin Chem Lab Med 48: 147-157.
52. Lassenius MI, Pietiläinen KH, Kaartinen K, Pussinen PJ, Syrjänen J, et al. (2011) Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation. Diabetes Care 34: 1809-1815.
53. Murch O, Collin M, Hinds CJ, Thiemermann C, (2007) Lipoproteins in inflammation and sepsis. I. Basic science. Intensive Care Med 33: 13-24.
54. Berbée JF, Havekes LM, Rensen PC, (2005) Apolipoproteins modulate the inflammatory response to lipopolysaccharide. J Endotoxin Res 11: 97-103.
55. Wu A, Hinds CJ, Thiemermann C, (2004) High-density lipoproteins in sepsis and septic shock: metabolism, actions, and therapeutic applications. Shock 21: 210-221.
56. Navab M, Reddy ST, Van Lenten BJ, Fogelman AM, (2011) HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms. Nat Rev Cardiol 8: 222-232.
57. Levels JH, Abraham PR, van den Ende A, van Deventer SJ, (2001) Distribution and kinetics of lipoprotein-bound endotoxin. Infect Immun 69: 2821-2828.
58. Levels JH, Marquart JA, Abraham PR, van den Ende AE, Molhuizen HO, et al. (2005) Lipopolysaccharide is transferred from high-density to low-density lipoproteins by lipopolysaccharide-binding protein and phospholipids transfer protein. Infect Immun 73: 2321-2326.
59. Chien JY, Jerng JS, Yu CJ, Yang PC, (2005) Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis. Crit Care Med 33: 1688-1693.
60. Barnes RL, Glantz SA, (2007) Endotoxins in tobacco smoke: shifting tobacco industry positions. Nicotine Tob Res 9: 995-1004.
61. Pauly JL, Paszkiewicz G, (2011) Cigarette smoke, bacteria, mold, microbial toxins, and chronic lung inflammation. J Oncol 2011: 819129.
62. Regueiro V, Campos MA, Morey P, Sauleda J, Agustí AG, et al. (2009) Lipopolysaccharide-binding protein and CD14 are increased in the bronchoalveolar lavage fluid of smokers. Eur Respir J 33: 273-281.
63. Laugerette F, Vors C, Géloën A, Chauvin MA, Soulage C, et al. (2011) Emulsified lipids increase endotoxemia: possible role in early postprandial low-grade inflammation. J Nutr Biochem 22: 53-59.
64. Hubacek JA, Büchler C, Aslanidis C, Schmitz G, (1997) The genomic organization of the genes for human lipopolysaccharide binding protein (LBP) and bactericidal permeability increasing protein (BPI) is highly conserved. Biochem Biophys Res Commun 18 236: 427-430.
65. Kirschning CJ, Au-Young J, Lamping N, Reuter D, Pfeil D, et al. (1997) Similar organization of the lipopolysaccharide-binding protein (LBP) and phospholipid transfer protein (PLTP) genes suggests a common gene family of lipid-binding proteins. Genomics 15 46: 416-425.
66. Vercelli D, (2010) Gene-environment interactions in asthma and allergy: the end of the beginning? Curr Opin Allergy Clin Immunol 10: 145-148.
67. Vainas T, Stassen FR, Bruggeman CA, Welten RJ, van den Akker LH, et al. (2006) Synergistic effect of Toll-like receptor 4 and CD14 polymorphisms on the total atherosclerosis burden in patients with peripheral arterial disease. J Vasc Surg 44: 326-332.
68. Morange PE, Tiret L, Saut N, Luc G, Arveiler D, et al. (2004) TLR4/Asp299Gly, CD14/C-260T, plasma levels of the soluble receptor CD14 and the risk of coronary heart disease: The PRIME Study. Eur J Hum Genet 12: 1041-1049.